The effects of secretin on prolactin, estradiol, vasoactive intestinal polypeptide, and somatostatin levels in women

in European Journal of Endocrinology
Restricted access


The effect of graded doses of intravenous secretin (0.5, 1.0, and 2.0 CU · kg−1 · h−1) on serum prolactin and estradiol levels, as well as plasma vasoactive intestinal polypeptide and somatostatin levels was studied in 6 normally cycling and healthy women, and compared with the hormone levels obtained by a control infusion with physiologic saline (0.15 mol/l). A significant decrease in serum prolactin concentrations was found with increasing doses of secretin at steady-state levels of plasma secretin (+30 to +60 min). A significant negative correlation (p<0.007, r=−0.2764) existed between serum prolactin and plasma secretin concentrations at steady-state conditions. No effect of graded doses of secretin was observed on serum estradiol levels and plasma concentrations of vasoactive intestinal polypeptide and somatostatin. The results suggest a dose-related inhibitory effect of secretin on prolactin release in women.


     European Society of Endocrinology

Related Articles

Article Information


All Time Past Year Past 30 Days
Abstract Views 105 105 5
Full Text Views 80 70 0
PDF Downloads 19 17 0



Google Scholar